Inclusion Criteria:  Biological males and females who are at least 18 years of age and diagnosed with heart failure (HF) with reduced ejection fraction (systolic HF) corresponding to the New York Heart Association Classes 2 to 4 (NYHA II-IV) for 3 or more months prior to enrollment Left ventricular ejection fraction (LVEF) less than or equal to 40% with documentation by ventriculography or quantitative echocardiography (these data are readily available as per standard of care) No worsening of HF for 1 month prior to recruitment, as determined by a referring physician Medical treatment determined by the referring physician adheres to Canadian Cardiovascular Society guideline-directed therapy for at least 1 month prior to enrollment Oral and written comprehension of English Personal access to a computer Informed written consent  Exclusion Criteria:  Mid-range or preserved ejection fraction [these patients often exhibit normal brain natriuretic peptide levels and a high rate of non-cardiac mortality (approximately 30%), which would confound our evaluation of ODYSSEE-vCHAT] Scheduled for advanced surgical therapy (e.g., heart transplantation or implantation of a left ventricular assistive device) within 3 months of enrollment Record of significant comorbidities at enrollment that prohibits full participation (e.g., dementia, psychosis, or severe depression) HF secondary to uncorrected valvular cardiomyopathy, predominant right-sided HF, or a non-cardiac disease